Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes”
Year: 2001
Type: article
Source: Neurology
DOI: 10.1212/wnl.57.4.731
Authors: M. Filippi, M. Rovaris, M. A. Rocca, M. P. Sormani, J. S. Wolinsky, G. Comi, the European/Canadian Glatiramer Acetate Study Group*
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1967733776
